Repurposing of propafenone, an FDA approved anti-arrhythmic drug for antileishmanial therapy - ScienceDirect.com
  Abstract 4146462: Ablation versus Anti-arrhythmic Drug Therapy for Ventricular Tachycardia in Patients with Ischemic Heart Disease: A Systematic Review and Meta-analysis of Randomized Controlled Trials - American Heart Association Journals
  Ablation by three-dimensional electroanatomical mapping versus anti-arrhythmic drug therapy: a cost-utility analysis in the treatment of idiopathic ventricular arrhythmias - BMC Cardiovascular Disorders
  Clinical Significance and Management of Atrioventricular Block Associated With Bradycardic/Antiarrhythmic Drug Therapy: Drug-Induced or Drug-Revealed? - Wiley Online Library
  Do extra-pulmonary triggers or autonomic neural activity affect rhythm control by anti-arrhythmic drugs in patients with post-ablation atrial fibrillation recurrence? - Frontiers
  Catheter Ablation or Antiarrhythmic Drugs for Ventricular Tachycardia - The New England Journal of Medicine
  A python approach for prediction of physicochemical properties of anti-arrhythmia drugs using topological descriptors - Nature
  Pro-arrhythmic effect of escitalopram and citalopram at serum concentrations commonly observed in older patients – a study based on a cohort of 19,742 patients - The Lancet